Summary
Routine clinical follow-up for distant metastatic disease among women with early stage breast cancer is of uncertain clinical benefit. In order to evaluate current practice patterns, we administered a mailed survey to a stratified random sample of physician members of the American Society of Clinical Oncology (ASCO) (N = 435). The survey assessed the frequency and motivation for ordering follow-up medical tests in asymptomatic postmenopausal women with stage I or II breast cancer. The response rate was 55%, distributed as 39% radiation oncologists, 32% medical oncologists, and 29% surgeons. In the first year after treatment, physicians performed, on average, one physical examination every 3 months, one blood panel (CBC, alkaline phosphatase and liver function tests) every 4 months, and one chest radiograph every 9 months. In addition, 38% of the respondents ordered CEA and 21% ordered CA 15-3 levels, 28% ordered bone scans, and less than 4% ordered CT scans, bone surveys, or bone marrow biopsies in the first year after treatment. A logistic regression analysis controlling for physician age, gender, sub-specialty, practice type, years of experience, number of breast cancer patients treated annually, geographic region, and community size, showed that surgeons were less likely to order blood tests (p < 0.001) and tumor markers (p < 0.0029) than medical oncologists in years 3 and 5 of follow-up. Compared to physicians practicing in the northeast, those from the midwest were less likely to order chest radiographs in year 3 of follow-up (p = 0.0028). Other provider characteristics had no significant effect on test ordering behavior. The results of this survey suggest that relatively uniform practice patterns in regard to the follow-up of postmenopausal women with early stage breast cancer exist among ASCO physicians.
References
Fowble B, Goodman RL, Glick JH, Rosato EF: Breast cancer treatment. A comprehensive guide to management. Mosby-Year Book, Inc., St. Louis, 1991, Chapter 16, pp 403–419
Division of Cancer Prevention and Control. Cancer statistics review 1973–1988. Bethesda, MD: US Department of Health and Human Services. National Cancer Institute. 1991 (NIH Publication No. 91-2789)
Donegan WL, Spratt JS (eds): Cancer of the Breast. Third edition. W.B. Saunders, Philadelphia, 1988, Chapter 6, pp 125–167
Brinkley D, Haybittle JL: Long term survival of women with breast cancer. Lancet i: 1118, 1984
Swartz M: Summary: A model of screening for breast cancer. Presented at the Michigan Cancer Foundation Workshop, Detroit, 1977 May
Frazier TG, Copeland EM, Gallagher HS, Paulus DD, White EC: Prognosis and treatment in minimal breast cancer. Am J Surg 133: 697–701, 1977
Greenwald P, Sondik E (eds): Cancer Control Objectives for the Nation: 1985–2000. NCI Monographs 2: 27, 1986
Duncan W, Kerr GR: The curability of breast cancer. Br Med J ii: 781–783, 1976
Schapira DV, Urban N: A minimalist policy for breast cancer surveillance. JAMA 265: 380–382, 1991
Loomer L, Brockschmidt JK, Muss HB, Saylor G: Postoperative follow-up of patients with early breast cancer. Cancer 67: 55–60, 1991
Kamby C, Vejborg I, Kristensen B, Olsen LO, Mouridsen HT: Metastatic pattern in recurrent breast cancer. Cancer 62: 2226–2233, 1988
Harris JR, Hellman S, Henderson IC, Kinne DW: Breast Diseases. Second Edition. JB Lippincott, Philadelphia, 1991, Chapter 19, pp 505–525
Wagman LD, Sanders RD, Terz JJ, Beatty JD, Kokal WA, Riihimaki DU: The value of symptom directed evaluation in the surveillance for recurrence of carcinoma of the breast. Surg Gynecol Obstet 172: 191–196, 1991
Hietanen P: Chest radiography in the follow-up of breast cancer. Acta Radiol Oncol 25: 15–18, 1986
Hughes LE, Courtney SP: Follow up of patients with breast cancer. Br Med J 290: 1229–1230, 1985
Arnstein NB, Harbert JC, Byrne PJ: Efficacy of bone and liver scanning in breast cancer patients treated with adjuvant chemotherapy. Cancer 54: 2243–2247, 1984
Pandya J, McFadden ET, Kalish LA, Tormey DC, Taylor SG, Falkson G: A retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group Adjuvant chemotherapy trials for breast cancer. Cancer 55: 202–205, 1985
Marrazzo A, Solina G, Puccia V, Fiorentino E, Bazan P: Evaluation of routine follow-up after surgery for breast carcinoma. J Surg Oncol 32: 179–181, 1986
Ojeda MB, Alonso MC, Bastus R, Alba E, Piera JM, Lopez JJ: Follow-up of breast cancer stages I and II. An analysis of some common methods. Eur J Clin Oncol 23: 419–423, 1987
Schunemann H, Langecker PJ, Ellgas W, Leonhardt A, Merkl H: Value of bone scanning in the follow-up of breast cancer patients. J Cancer Res Clin Oncol 116: 486–491, 1990
Eiseman B, Feiner AS: Cost-effective followup of the cancer patient. Postgraduate Medicine 83: 119–126, 1988
Thomsen HS, Rasmussen D, Munck O, Lund JO, Gerhard-Nielsen V, Terkildsen Tet al.: Bone metastases in primary operable breast cancer. The role of yearly scintigraphy. Eur J Cancer Clin Oncol 23: 779–781, 1987
Baker RR, Holmes ER, Anderson POet al. An evaluation of bone scans as screening procedures for occult metastases in primary breast cancer. Ann Surg 186: 363–368, 1977
Burkett FE, Scanlon EF, Garces RM, Khanderkar JDL: The value of bone scans in the management of patients with carcinoma of the breast. Surg Gynecol Obstet 149: 523–525, 1979
McNeil B, Pace PD, Gray Eet al.: Pre-operative and follow-up bone scans in patients with primary carcinoma of the breast. Surg Gynecol Obstet 147: 745–748, 1978
Wickerham L, Fisher B, Cronin Wet al.: The efficacy of bone scanning in the follow-up of patients with operable breast cancer. Breast Cancer Res Treat 1: 24–84, 1983
Pedrazzini A, Gelbes R, Isley Met al.: First repeated bone scan in the observation of patients with operable breast cancer. J Clin Oncol 4: 389–394, 1986
Scanlon EF, Ovieda MA, Cunningham MP, Caprim JA, Khandekan JD, Cohen Eet al.: Preoperative and follow-up procedures on patients with breast cancer. Cancer 46: 977–979, 1980
Broyn T, Froyen J: Evaluation of routine follow-up after surgery for breast cancer. Acta Chir Scand 148: 401–404, 1982
Winchester DP, Sener SF, Khandekar JD, Oriedo MA, Cunningham MP, Caprini JAet al.: Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer 43: 956–960, 1979
Perez D, Milan J, Powles Tet al.: Detection of breast carcinoma metastases in bone: relative merits of x-rays and skeletal scintigraphy. Lancet 2: 613–616, 1983
Rossing N, Munck O, Nielsen Set al.: What do early bone scans tell about breast cancer patients? Eur J Cancer Clin Oncol 18: 629–636, 1982
Concoran RJ, Thrall JH, Kyle RWet al.: Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology 121: 663–667, 1976
Turner DTL, Ackery D, Fraser JD, Chaut ADB: The bone scan - has annual screening a place in the follow-up of breast cancer patients? Clin Oncol 3: 126–127, 1977
Cantwell B, Fennelly JJ, Jones M: Evaluation of follow-up methods to detect relapse after mastectomy in breast cancer patients. Ir J Med Sci 151: 1–5, 1982
Vestergaard A, Herrstedt J, Thomsen HS, Dombernowsky P, Zedeler K: The value of yearly chest x-ray in patients with stage I breast cancer. Eur J Cancer Clin Oncol 25: 687–689, 1989
Ormiston MC, Timoney AG, Qureshi AR: Is follow up of patients after surgery for breast cancer worthwhile? J Royal Soc Med 78: 920–921, 1985
Rutgers EJ, van Slooten EA, Kluck HM: Follow-up after treatment of primary breast cancer. Br J Surg 76: 187–190, 1989
Mansi JL, Earl HM, Powles TJ, Coombes RC: Tests for detecting recurrent disease in the follow-up of patients with breast cancer. Breast Cancer Res Treat 11: 249–254, 1988
Wiener SN, Sachs SH: An assessment of routine liver scanning in patients with breast cancer. Arch Surg 113: 126–127, 1978
Ingle JN, Tormey DC, Tan HK: The bone marrow examination in breast cancer. Diagnostic considerations and clinical usefulness. Cancer 41: 670–674, 1978
ASCO Membership Directory 1991. American Society of Clinical Oncology, 1991
U.S. Bureau of the Census, Statistical Abstract of the United States: (III edition) Washington, D.C., 1991
SAS/STAT User's Guidelines, SAS Institute Inc., Cary, 1988, p 189
Breslow NE, Day NE: Statistical methods in cancer research. International Agency for Research on Cancer, Lyon, 1980, Chapter 6, p. 192–248
Dunnett CW: A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50: 1096–1121, 1955
Tomin R, Donnegan WL: Screening for recurrent breast cancer - its effectiveness and prognostic value. J Clin Oncol 5: 62–67, 1987
Muss HB, McNamara MJC, Connelly RA: Follow-up after stage II breast cancer: A comparative study of relapsed versus non-relapsed patients. Am J Clin Oncol 4: 451–455, 1988
Kunkler IH, Merrick MV: The value of non-staging skeletal scintigraphy in breast cancer. Clinical Radiology 37: 561–562, 1986
Gerber FH, Goodreau JJ, Kirchner PT, Fouty WJ: Efficacy of preoperative and postoperative bone scanning in the management of breast cancer. N Engl J Med 297: 300–303, 1977
Khanderkar JD, Burkett FE, Scanlon EF: Sensitivity, specificity and predictive value of bone scans in breast cancer. Abstract. Proc Soc Clin Oncol 19: 379, 1978
Zwaveling A, Albers GHR, Felthuis W, Hermans J: An evaluation of routine follow-up for detection of breast cancer recurrences. J Surg Oncol 34: 194–197, 1987
Wertheimer MD: Commentary. Against minimalism in breast cancer follow-up. JAMA 265: 396–397, 1991
Johnston FRC: Adverse effect of postoperative irradiation on the breast. Adv Med Oncol Res Education 12: 401, 1978
Horton J: Follow-up of breast cancer patients. Cancer 53: 790–797, 1984
Commission on Cancer, American College of Surgeons: The patient with cancer: Guidelines for follow-up, p 60, 1976
Brown ML: The national economic burden of cancer: An update. JNCI 82: 1811–1814, 1990
Baker MS, Kessler LG, Urban N, Smucker RC: Estimating the treatment costs of breast and lung cancer. Medical Care 29: 40–49, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simon, M.S., Hoff, M., Hussein, M. et al. An evaluation of clinical follow-up in women with early stage breast cancer among physician members of the American Society of Clinical Oncology. Breast Cancer Res Tr 27, 211–219 (1993). https://doi.org/10.1007/BF00665691
Issue Date:
DOI: https://doi.org/10.1007/BF00665691